NCT06798961Active, not recruiting
Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)
Source: ClinicalTrials.gov · Last updated 14 Mar 2025
Brief summary (registry, in English)
The investigators propose a secondary chart review using EMR data to identify risk factors for sudden cardiac death in active-duty members diagnosed with an accessory pathway between the ages of 18-40.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 23 Jan 2025
- Start date
- 1 Nov 2024
- Primary completion date
- Dec 2025
- Lead sponsor
- United States Naval Medical Center, San Diego
- Diseases
- Parkinson disease
- NCT number
- NCT06798961
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Nov 2024 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient without the diagnosis of Wolf Parkinson's White (WPW) syndrome
Who the study is looking for
- Active Duty between ages 18-40 who were diagnosed with an accessory pathway between 1/1/1990 - 5/30/2024.
Age in the registry: 18 years to 40 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Naval Medical Center -San Diego Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.